How do I buy Jazz Pharmaceuticals (JAZZ) stock?

Buying Jazz Pharmaceuticals (JAZZ) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and verify your identity. Make a deposit. Search for the code "JAZZ", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy JAZZ by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

How do I tell if JAZZ is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Jazz Pharmaceuticals (JAZZ) Stock

Q: What is the minimum investment for JAZZ on Gotrade?

On Gotrade , you don't have to buy a full share. With fractional shares, you can start investing in Jazz Pharmaceuticals from just $1. A small budget shouldn't stop you from building a US stock portfolio.

NSQ · JAZZ

Trade JAZZ

Key stats

Market cap: $15.93B
Price / Earnings ratio: 76.5x
EPS (TTM): $3.64
Volume: Loading
52-week high: $266.38
52-week low: $132.10
EPS vs analyst estimate: +49.7%Q3 FY25 · $8.13 vs $5.43

Source: third-party data provider, as of November 13, 2026

EPS estimate: analyst consensus

Compare with JAZZ

Technical indicators

RSI 14: 67.98
MACD 12/26/9: 4.52
EMA 9 of MACD: -0.35
MACD histogram: 4.87
SMA 50: $229.35; Price above SMA 50
EMA 50: $229.01; Price above EMA 50
SMA 200: $219.26; Price above SMA 200
EMA 200: $213.53; Price above EMA 200

Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.

Analyst ratings

Analyst consensus: Buy

Based on 10 analyst ratings

Strong Sell0

Sell0

Hold0

Buy10

Strong Buy0

Third-party analyst opinion, not a recommendation from Gotrade.

Financials

Performance

Revenue

Net income

Net margin %

2021

2022

2023

2024

2025

5B3B2B0

Debt & Balance Sheet

Total assets

Total liabilities

2021

2022

2023

2024

2025

15B10B5B0

Revenue to Profit

2025

$4.3B

Revenue

$0.0

Cost of revenue

$3.8B

Gross profit

$0.0

Operating expenses

$-356.1M

Net income

Earnings

EPS forecast

Actual EPS

$8.13

$5.43

Q3FY25

$6.01

Q4FY25

$4.08

Q1FY26

$5.07

Q2FY26

$5.71

Q3FY26

The market is expecting earnings per share of $5.71 for this quarter. The company has not yet shared when it is announcing earnings.

Source: third-party data provider

About Jazz Pharmaceuticals

At Jazz Pharmaceuticals, our purpose is to innovate to transform the lives of patients and their families. We are focused on developing life-changing medicines for people with serious diseases — often with limited or no options — so they can live their lives more fully. By transforming biopharmaceutical discoveries into novel medicines, we are working to give people around the world the opportunity to redefine what’s possible – to make the “small wins” big again.

SectorHealthcare

IndustryBiotechnology

Employees2,890

CEOMs. Renee D. Gala

IPO DateJun 1, 2007

HeadquartersDublin, Ireland

Key Executives

Name	Title	Year Born
Ms. Renee D. Gala	President, CEO & Director	1972
Mr. Bruce C. Cozadd	Co-Founder & Chairman	1964
Mr. Philip L. Johnson	Executive VP & CFO	1964
Ms. Neena M. Patil J.D.	Executive VP & Chief Legal Officer	1975
Dr. Robert Iannone M.D.	Executive VP, Chief Medical Officer and Global Head of Research & Development	1967
Ms. Samantha Pearce	Executive VP & Chief Commercial Officer	1966
Ms. Patricia Carr	Senior VP & Chief Accounting Officer	1971
Mr. John D. Bluth	Head of Investor Relations	1973
Ms. Heidi Manna	Executive VP & Chief People Officer	1971
Dr. Jed Black M.D.	Senior Vice President of Sleep & CNS Medicine	—

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021											-13.9	+5.2
2022	+6.0	-2.4	+13.9	+0.8	-4.8	+5.7	-1.6	+2.8	-15.2	+6.2	+7.8	+1.8
2023	+0.2	-11.0	+4.1	-3.4	-9.3	-4.0	+5.1	+10.7	-10.0	-0.6	-7.2	+3.3
2024	-3.3	-3.9	+1.3	-6.9	-4.6	+0.9	+3.6	+1.4	+1.9	+0.9	+10.1	+1.3
2025	+0.5	+17.7	-11.5	-6.4	-7.8	-2.0	+4.7	+10.6	+1.7	+0.5	+27.6	-1.2
2026	-5.0	+13.6	-0.7	+7.8	+16.7	+3.6	+6.5	-0.4	-5.0	-7.3	+15.8

Stocks in the same sector

Vertex Pharmaceuticals

ABEO

Abeona Therapeutics Inc.

FAQ

Buying Jazz Pharmaceuticals (JAZZ) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and verify your identity.
Make a deposit.
Search for the code "JAZZ", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy JAZZ by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full share. With fractional shares, you can start investing in Jazz Pharmaceuticals from just $1. A small budget shouldn't stop you from building a US stock portfolio.

At the moment, Jazz Pharmaceuticals (JAZZ) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track JAZZ's performance via the price chart in the Gotrade app.

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place an order any time. It goes through when the US market (NYSE/NASDAQ) opens: 9:30 AM to 4:00 PM New York time, Monday to Friday. Pre-market and after-hours trading are open too.

The market is closed on US public holidays. The Gotrade app shows whether the market is open.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trade Faster. Easier. Smarter.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

Jazz Pharmaceuticals (JAZZ) Stock

Key stats

Compare with JAZZ

Recent news

JAZZ Q3 Earnings & Sales Beat Estimates, Raises '26 Sales View

JAZZ Q3 Earnings & Sales Beat Estimates, Raises '26 Sales View

Jazz Pharmaceuticals Q3 Earnings Call Highlights

Jazz Pharmaceuticals Q3 Earnings Call Highlights

Jazz (JAZZ) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Jazz (JAZZ) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Jazz Pharmaceuticals (JAZZ) Reports Q3 Loss, Tops Revenue Estimates

Jazz Pharmaceuticals (JAZZ) Reports Q3 Loss, Tops Revenue Estimates

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

JAZZ Q3 Earnings & Sales Beat Estimates, Raises '26 Sales View

JAZZ Q3 Earnings & Sales Beat Estimates, Raises '26 Sales View

Jazz Pharmaceuticals Q3 Earnings Call Highlights

Jazz Pharmaceuticals Q3 Earnings Call Highlights

Jazz (JAZZ) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Jazz (JAZZ) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Jazz Pharmaceuticals (JAZZ) Reports Q3 Loss, Tops Revenue Estimates

Jazz Pharmaceuticals (JAZZ) Reports Q3 Loss, Tops Revenue Estimates

Where Will Jazz Pharmaceuticals Be in 5 Years? Oncology Is Becoming Its Growth Engine

Where Will Jazz Pharmaceuticals Be in 5 Years? Oncology Is Becoming Its Growth Engine

Analysts Estimate Jazz Pharmaceuticals (JAZZ) to Report a Decline in Earnings: What to Look Out for

Analysts Estimate Jazz Pharmaceuticals (JAZZ) to Report a Decline in Earnings: What to Look Out for

Is JAZZ Stock Still a Smart Way to Play Medical Cannabis?

Is JAZZ Stock Still a Smart Way to Play Medical Cannabis?

Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value Stock

Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value Stock

Jazz Pharmaceuticals Targets $5B Zanidatamab Opportunity as Oncology Revenue Tops $1B

Jazz Pharmaceuticals Targets $5B Zanidatamab Opportunity as Oncology Revenue Tops $1B

Jazz Pharmaceuticals Sees $3B-$5B Ziihera Opportunity as Pipeline Expands

Jazz Pharmaceuticals Sees $3B-$5B Ziihera Opportunity as Pipeline Expands

About Jazz Pharmaceuticals

Key Executives

Fundamentals

Valuation

Profitability

Trading

Technical indicators

Analyst views

Seasonality

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade